Calcium channel autoantibodies in the lambert‐eaton myasthenic syndrome

Annals of Neurology

Volumn 29, Issue 3, 1991, Pages 307-314

  Leysm, Katherine ^a   Lang, Bethan ^a   Johnston, Irene ^a   Newsom‐Davis, John ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EATON LAMBERT SYNDROME; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ACTION POTENTIALS; ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CALCIUM CHANNELS; FEMALE; HUMAN; KINETICS; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; MIDDLE AGE; PEPTIDES, CYCLIC; PRECIPITIN TESTS; TUMOR CELLS, CULTURED;

EID: 0026022446     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410290313     Document Type: Article

References (40)

1. Quantal components of end‐plate potentials in the myasthenic syndrome
2. The Lambert‐Eaton myasthenic syndrome: a review of 50 cases
3. Autoimmunity to the voltage‐gated calcium channel underlies the Lambert‐Eaton myasthenic syndrome, a paraneoplastic disorder
4. Autoimmunity in the Lambert‐Eaton myasthenic syndrome
5. Increased frequency of IgG heavy chain marker Glm(2) and of HLA‐B8 in Lambert‐Eaton myasthenic syndrome with and without associated lung carcinoma
6. Plasma exchange and immunosuppressive drug treatment in the Lambert‐Eaton myasthenic syndrome
7. Autoimmune aetiology for myasthenic (Eaton‐Lambert) syndrome
8. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse
9. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse
10. Are the presynaptic membrane particles the calcium channels
11. Passive transfer of Lambert‐Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones
12. Paucity and disorganization of presynaptic membrane active zones in the Lambert‐Eaton myasthenic syndrome
13. Calcium spike electrogenesis and other electrical activity in continuously cultured small cell carcinoma of the lung
14. 2+ flux in a human small cell lung carcinoma line
15. Antagonism of voltage‐gated calcium channels in small cell carcinomas of patients with and without Lambert‐Eaton myasthenic syndrome by autoantibodies, ω‐conotoxin and adenosine
16. Calcium channels: structure and function
17. 2+ flux in tumor cells correlates with disease severity
18. Response of the Lambert‐Eaton myasthenic syndrome to treatment of associated small cell lung carcinoma
19. A venom peptide with a novel presynaptic blocking action
20. Calcium channel antagonists: ω‐conotoxin defines a new high affinity site
21. ω‐Conotoxin binding and effects on calcium channel function in human neuroblastoma and rat pheochromocytoma cell lines
22. Voltage‐operated calcium channels in small cell lung carcinoma cell lines: pharmacological function and immunological properties
23. Calcium channel autobodies in Lambert‐Eaton myasthenic syndrome
24. Specificity of calcium channel autoantibodies in Lambert‐Eaton myasthenic syndrome
25. Autoantibodies bind solubilized calcium channel‐ω‐conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert‐Eaton myasthenic syndrome
26. Protein measurement with the Folin‐Phenol reagent
27. The isolation of gamma‐globulins from blood serum by Rivanol
28. Action of Lambert‐Eaton myasthenic syndrome IgG at motor nerve terminals
29. Selected IgG rapidly induces Lambert‐Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities
30. Lambert‐Eaton myasthenic syndrome: the lack of short‐term effects of serum factors on neuromuscular transmission
31. Lambert‐Eaton myasthenic syndrome: early morphological effects IgG on the presynaptic membrane active zones
32. Lambert‐Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation
33. Anti‐acetylcholine receptor antibodies
34. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange
35. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line
36. IgG from patients with Lambert‐Eaton syndrome blocks voltage‐dependent calcium channels
37. Immunoglobulins of Lambert‐Eaton myasthenic syndrome inhibit rat pituitary hormone release
38. ω‐Conotoxin: direct and persistent blockade of specific types of calcium channels in neurones but not muscle
39. Ca currents in human neuroblastoma IMR32 cells: kinetics, permeability and pharmacology
40. The inhibitory effects of omega‐conotoxins on Ca channels and synapses